Reply to Harsanyi et al. Comment on "Hasan et al. Clinico-Pathological Features and Immunohistochemical Comparison of p16, p53, and Ki-67 Expression in Muscle-Invasive and Non-Muscle-Invasive Conventional Urothelial Bladder Carcinoma. Clin. Pract. 2023, 13, 806-819"
回复 Harsanyi 等人的评论：“Hasan 等人，《肌层浸润性和非肌层浸润性常规尿路上皮膀胱癌中 p16、p53 和 Ki-67 表达的临床病理特征和免疫组织化学比较》，Clin. Pract. 2023, 13, 806-819”。
期刊:Clinics and Practice
影响因子:2.2
doi:10.3390/clinpract16010010
Hasan, Abdulkarim; Mohammed, Yasien; Basiony, Mostafa; Hanbazazh, Mehenaz; Samman, Abdulhadi; Abdelaleem, Mohamed Fayek; Nasr, Mohamed; Abozeid, Hesham; Mohamed, Hassan Ismail; Faisal, Mahmoud; Mohamed, Eslam; Ashmawy, Diaa; Tharwat, Mohamed; Morsi, Deaa Fekri; Farag, Abeer Said; Ahmed, Eman Mohamed; Aly, Noha M; Abdel-Hamied, Hala E; E A Salama, Doaa; Mandour, Essam
